A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomized trial
F. Althabe,JM Belizán,EM McClure,J. Hemingway-Foday,M. Berrueta,A. Mazzoni,A. Ciganda,SS Goudar,BS Kodkany,NS Mahantshetti,SM Dhaded,GM Katageri,MC Metgud,AM Joshi,MB Bellad,NV Honnungar,RJ Derman,S. Saleem,O. Pasha,S. Ali,F. Hasnain, R.L. Goldenberg, F. Esamai,P. Nyongesa,S. Ayunga, EA Liechty, AL Garces, L. Figueroa, KM Hambidge, NF Krebs, A. Patel,A. Bhandarkar,M. Waikar,PL Hibberd,E. Chomba, WA Carlo, A. Mwiche,M. Chiwila,A. Manasyan,S. Pineda,S. Meleth,V. Thorsten,K. Stolka, D.D. Wallace, M. Koso-Thomas, A.H. Jobe and P.M. Buekens. A population-based, multifaceted strategy to implement prenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomized trial. Lancet. 2015;385(9968):10.1016/s0140-6736(14)61651-2.

